Prosperity Consulting Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-696
Closed -$244K 531
2025
Q4
$244K Sell
696
-14
-2% -$4.73K 0.01% 450
2025
Q3
$229K Buy
710
+141
+25% +$43.9K 0.01% 467
2025
Q2
$221K Buy
569
+55
+11% +$22.1K 0.02% 424
2025
Q1
$224K Buy
+514
New +$206K 0.02% 425
2024
Q4
Sell
-465
Closed -$242K 470
2024
Q3
$242K Buy
+465
New +$248K 0.02% 409

Other funds holding ELV

Prosperity Consulting Group's ELV Position: Q1 2026 in Review

Prosperity Consulting Group sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 696 shares — an estimated $244K sold.

Prosperity Consulting Group first reported a position in ELV in Q3 2024 and held it in 5 quarters. The position peaked at $244K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Prosperity Consulting Group reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Prosperity Consulting Group sold 696 Elevance Health shares in Q1 2026, an estimated $244K.
  • Prosperity Consulting Group first reported a position in Elevance Health in Q3 2024 and held it in 5 quarters.
  • Prosperity Consulting Group's Elevance Health position peaked at $244K in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Prosperity Consulting Group's 13F filing for Q1 2026, filed 5 May 2026.